title: Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.
abstract: Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including AKT and protein kinase C (PKC), and is implicated in important cellular processes including survival, metabolism and tumorigenesis. In large cohorts of nevi and melanoma samples, PDK1 expression was significantly higher in primary melanoma, compared with nevi, and was further increased in metastatic melanoma. PDK1 expression suffices for its activity, owing to auto-activation, or elevated phosphorylation by phosphoinositide 3'-OH-kinase (PI3K). Selective inactivation of Pdk1 in the melanocytes of Braf(V600E)::Pten(-/-) or Braf(V600E)::Cdkn2a(-/-)::Pten(-/-) mice delayed the development of pigmented lesions and melanoma induced by systemic or local administration of 4-hydroxytamoxifen. Melanoma invasion and metastasis were significantly reduced or completely prevented by Pdk1 deletion. Administration of the PDK1 inhibitor GSK2334470 (PDKi) effectively delayed melanomagenesis and metastasis in Braf(V600E)::Pten(-/-) mice. Pdk1(-/-) melanomas exhibit a marked decrease in the activity of AKT, P70S6K and PKC. Notably, PDKi was as effective in inhibiting AGC kinases and colony forming efficiency of melanoma with Pten wild-type (WT) genotypes. Gene expression analyses identified Pdk1-dependent changes in FOXO3a-regulated genes, and inhibition of FOXO3a restored proliferation and colony formation of Pdk1(-/-) melanoma cells. Our studies provide direct genetic evidence for the importance of PDK1, in part through FOXO3a-dependent pathway, in melanoma development and progression.
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Scortegagna
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: C
authors.initials: C
authors.lastname: Ruller
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Feng
authors.affiliation: Department of Dermatology, Medicine and Pathology, Yale University, New Haven, CT, USA.
authors.forename: R
authors.initials: R
authors.lastname: Lazova
authors.affiliation: Department of Dermatology, Medicine and Pathology, Yale University, New Haven, CT, USA.
authors.forename: H
authors.initials: H
authors.lastname: Kluger
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: J-L
authors.identifier: 000000026487081X
authors.initials: JL
authors.lastname: Li
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: S K
authors.initials: SK
authors.lastname: De
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Rickert
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Pellecchia
authors.affiliation: Department of Dermatology, Medicine and Pathology, Yale University, New Haven, CT, USA.
authors.forename: M
authors.initials: M
authors.lastname: Bosenberg
authors.affiliation: Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Ronai
mesh_terms: D000818:Animals; D063646:Carcinogenesis / Q000378:metabolism; D045744:Cell Line, Tumor; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000378:metabolism; D055786:Gene Knockout Techniques; D006801:Humans; D007191:Indazoles / Q000494:pharmacology; D008175:Lung Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000556:secondary; D008207:Lymphatic Metastasis; D008546:Melanoma, Experimental / Q000201:enzymology / Q000235:genetics* / Q000556:secondary; D051379:Mice; D018345:Mice, Knockout; D020125:Mutation, Missense; D051059:PTEN Phosphohydrolase / Q000172:deficiency / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics* / Q000378:metabolism; D011743:Pyrimidines / Q000494:pharmacology; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D046888:Tissue Array Analysis
chemical_list: D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; C474033:FoxO3 protein, mouse; C555257:GSK 2334470; D007191:Indazoles; C000631429:PDK1 protein, human; C000631433:Pdk1 protein, mouse; D011743:Pyrimidines; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; C482120:Braf protein, mouse; D017346:Protein Serine-Threonine Kinases; D048493:Proto-Oncogene Proteins B-raf; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse
references.citation: J Biol Chem. 2011 Feb 25;286(8):6433-48
references.pmid: 21118801
references.citation: Pigment Cell Melanoma Res. 2009 Feb;22(1):4-5
references.pmid: 19054340
references.citation: Cancer Cell. 2009 Jul 7;16(1):21-32
references.pmid: 19573809
references.citation: Cancer Cell. 2013 Mar 18;23(3):406-20
references.pmid: 23453624
references.citation: Cancer Genet Cytogenet. 2008 Mar;181(2):100-7
references.pmid: 18295661
references.citation: J Med Chem. 2011 Mar 24;54(6):1871-95
references.pmid: 21341675
references.citation: Biochem J. 1999 Sep 1;342 ( Pt 2):287-92
references.pmid: 10455013
references.citation: Genes Dev. 2012 Jun 1;26(11):1131-55
references.pmid: 22661227
references.citation: Transl Oncol. 2012 Dec;5(6):453-60
references.pmid: 23401739
references.citation: Curr Biol. 2005 Oct 25;15(20):1839-46
references.pmid: 16243031
references.citation: J Biol Chem. 2005 May 27;280(21):20814-23
references.pmid: 15781459
references.citation: Mol Cell. 2005 Aug 5;19(3):309-20
references.pmid: 16061178
references.citation: J Biol Chem. 2010 Jan 8;285(2):903-13
references.pmid: 19910471
references.citation: Pigment Cell Melanoma Res. 2012 Nov;25(6):819-31
references.pmid: 22883054
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14057-62
references.pmid: 15383658
references.citation: J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
references.pmid: 17646672
references.citation: Nucleic Acids Res. 2010 Dec;38(22):e204
references.pmid: 20929874
references.citation: EMBO J. 2002 Jul 15;21(14):3728-38
references.pmid: 12110585
references.citation: Genesis. 2006 May;44(5):262-7
references.pmid: 16676322
references.citation: Genome Biol. 2004;5(10):R80
references.pmid: 15461798
references.citation: Curr Top Microbiol Immunol. 2010;346:9-29
references.pmid: 20563709
references.citation: Cancer Res. 2011 Apr 15;71(8):3052-65
references.pmid: 21493594
references.citation: Neoplasia. 2012 Aug;14(8):719-31
references.pmid: 22952425
references.citation: Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20126-31
references.pmid: 21041639
references.citation: Clin Cancer Res. 2009 May 1;15(9):3029-36
references.pmid: 19383818
references.citation: Semin Cell Dev Biol. 2004 Apr;15(2):161-70
references.pmid: 15209375
references.citation: Cancer Res. 2009 Aug 1;69(15):6299-306
references.pmid: 19602588
references.citation: Cancer Cell. 2007 May;11(5):447-60
references.pmid: 17482134
references.citation: Biochem J. 2011 Jan 15;433(2):357-69
references.pmid: 21087210
references.citation: J Exp Med. 2009 Oct 26;206(11):2441-54
references.pmid: 19808258
references.citation: Stat Appl Genet Mol Biol. 2004;3:Article3
references.pmid: 16646809
references.citation: Nat Genet. 2009 May;41(5):544-52
references.pmid: 19282848
references.citation: Biochem J. 2012 Dec 1;448(2):285-95
references.pmid: 23030823